Neelam Shahani

Title: Neelam Shahani: Innovator in Mental Health Treatment

Introduction

Neelam Shahani is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of mental health through her innovative research and patenting efforts. Her work focuses on the development of compounds that target stress-induced disorders, including major mental illnesses.

Latest Patents

Neelam Shahani holds a patent for "GAPDH cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness." This patent addresses the role of oxidative stress in major mental illnesses, such as schizophrenia, mood disorders, and addiction. The research highlights the pronounced levels of oxidative stress found in the prefrontal cortex of DN-DISC1 mice, a model for major mental illnesses. The findings indicate that GAPDH-Siah1 binding is a crucial mechanism involved in these disorders, and the invention provides compounds that inhibit this binding, offering potential therapeutic benefits.

Career Highlights

Neelam Shahani is affiliated with Johns Hopkins University, where she conducts her research. Her work has garnered attention for its innovative approach to understanding and treating mental health disorders. With a focus on the intersection of oxidative stress and mental illness, she has contributed valuable insights to the scientific community.

Collaborations

Neelam has collaborated with notable researchers, including Toshiaki Saito and Elki Takimoto. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in the field of mental health.

Conclusion

Neelam Shahani's innovative work in developing treatments for stress-induced disorders marks her as a significant figure in the field of mental health. Her contributions through patenting and research continue to pave the way for new therapeutic approaches.